ArticlePharmaceuticals (Basel, Switzerland)2022

Downstream Signaling of Inflammasome Pathway Affects Patients' Outcome in the Context of Distinct Molecular Breast Cancer Subtypes.

Concetta Saponaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.